Dominant optic atrophy (DOA) is the most common form of autosomally inherited (nonglaucomatous) optic neuropathy. The incidence has been estimated at 1:50 000' and prevalence as high as 1:10 OO0.2 It is named after the Danish ophthalmologist Poul Kjer,' who clinically characterised 19 families in 1959 . While evidence suggests that its highest prevalence may be in the Danish population, DOA has been described in pedigrees from France,4 the UK,`6 Cuba,7 and the USA, 8 although these pedigrees may all be of European descent. There are currently two known loci, an apparently more common one that maps to chromosome 3q28-qter (all of the pedigrees described above) and a much rarer locus on chromosome 18ql2.2-12.39 (see below).
Clinical features CLINICAL AND PATHOPHYSIOLOGICAL STUDIES OF

DOA
Autosomal dominant optic atrophy is an autosomally inherited disorder characterised by optic nerve pallor and reduced visual acuity.'0 First described clinically by Batten" and later by Kjer,3 it typically presents in childhood with bilateral visual loss that is usually symmetrical, temporal optic nerve pallor, centrocaecal visual field scotoma, and colour vision deficit."2" The intraocular pressure is normal and the optic disc is not cupped. The clinical profile should be clearly distinguished from acute Leber's hereditary optic neuropathy,'6 which has a sudden onset of visual loss in two eyes asynchronously and a later age of presentation (typically 18-35 years), although in the atrophic phase it may be very difficult to make this distinction without a family history. It may be more difficult to distinguish clinically dominant optic atrophy from X linked optic atrophy'7 18 without a family history. Recessively inherited optic atrophy is generally much more severe, presenting at the time of birth with nystagmus,'9 and is rare in isolation. 20 Other primary hereditary optic neuropathies, such as diabetes mellitus and insipidus with optic atrophy and deafness (DIDMOAD)2' and Behr's syndrome are multisystemic diseases.
Although Kjer' reported mental retardation in up to 10% of his original patients this would appear to be exceptional.22 Sensorineural deafness has been associated with dominantly inherited optic atrophy in a number of pedigrees, 2 28 One of these genes is HRY, the cloned human homologue of the Drosophila segmentation gene, hairy, which maps by in situ hybridisation to 3q28-q29.7`This gene encodes a. basic helix-loop-helix transcription factor7" and it is a member of a family of mammalian neurodevelopmental genes with Drosophila and rat74 homologues. Currently, at least 14 transcription factors are known to be required for eye formation and mammalian eye development.75 HRY has been studied in gain of function studies76 and neuronal differentiation has been shown to be suppressed by targeted disruption of the gene in mice homozygous for the mutation.77 HRY has been positioned onto the CEPH YAC 975f4 on a YAC contig that spans the OPAl region.6' HRY has been genetically mapped to an interval between markers D3S3562 and D3S1305,78 which is outside the critical interval for OPAl. An association has also been excluded by heteroduplex mutation detection (HET) and direct sequencing78 of the gene in its entirety.
An EST (stSG4566) highly similar to the gene for the flavoprotein (fp) subunit of succinate dehydrogenase (SDH2), a complex II mitochondrial respiratory enzyme, 79 plasmic for mutations 4160 and 14 484. 93 These features suggest that the optic nerve and inner retinal atrophy in LHON may be the result of a metabolic mitochondrial dysfunction leading to intramitochondrial calcification. It is hypothesised that the respiratory chain dysfunction leads to axoplasmic stasis and swelling, thereby blocking ganglion cell function and causing loss of vision.94 It is also believed that, in some ganglion cells, this loss of function may be reversible, but in others the apoptotic cell death pathway is activated, leading to extensive degeneration of the retinal ganglion cell layer and optic nerve. It has been suggested that ATP deficiency may be a common mechanism for visual loss in LHON and also in toxic and deficiency optic neuropathies,95 and we believe that a respiratory chain defect may be associated with dominant optic atrophy because of the similarities to LHON.
Although the genes for dominant optic atrophy have yet to be cloned, it is possible to speculate that the gene may be a nuclear encoded gene involved in the oxidative phosphorylation (OXPHOS) pathway, given the clinical and morphological similarities between dominant optic atrophy and LHON. Of the many enzymes involved in the OXPHOS chain of reactions, approximately one third are encoded by nuclear genes and two thirds are encoded by mitochondrial genes. Nuclear genes encoding mitochondrial enzymes may be duplicated in the genome. Thus it is possible that a mutation in either of these genomes can lead to a disruption in the OXPHOS cascade.
Genetic counselling in dominant optic atrophy Although the penetrance of dominant optic atrophy is high (0.98),59 there is considerable intra-and interfamilial phenotypic heterogeneity. The majority ofpatients present in early to mid childhood and the clinical diagnosis is generally reliable from 6 years of age and above, except in rare cases. As clinical assessment of the patient in order to be able to make a diagnosis. Genetic counselling in this condition currently relies on conventional risk assessment, in the absence of a diagnostic test. Linkage and haplotype analysis in larger pedigrees can provide evidence of a strong likelihood that a person carries the disease gene, but may be inconclusive. This is even more of a problem if there is genetic heterogeneity, as hereditary diseases resulting from mutations at different loci may be indistinguishable phenotypically. In this respect, the position of dominant optic atrophy is akin to the situation in autosomal dominant polycystic kidney disease, where PKD1 is said to account for 85% of patients, PKD2 for 10%, and an as yet unlinked locus (PKD3) for a few remaining families.96 Therefore, at present, the assignment of status in most families must rely upon clinical findings.
It is not possible to predict with any certainty the degree of severity of visual handicap and long term prognosis of a member of a family from one generation to the next. However, it is true to say that the severity of the condition by the age of adolescence reflects the overall level of visual function to be expected throughout most of the patient's adult life. There is evidence for slow deterioration in visual acuity, particularly reported by patients as they approach later middle age, which is not entirely explained by refractive changes. This deterioration has been documented to be particularly marked in some families. The reasons for this are not known, but may relate to the nature or type of mutation in those families.
Future prospects
The gene that causes dominant optic atrophy, OPAl, mapping to chromosome 3q28-qter, is likely to be cloned within the next few years. Given the abundant clinical heterogeneity of the condition, both within and between families, it will be fascinating to 
